iSelect Fund
  • Portfolio
  • Team
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Food is Health
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Insights
  • Contact
  • My iSelect
    • My iSelect Login
Select Page

Florida Welcomes a New Era in Agricultural Advancements

Read more

Geneoscopy Receives Accreditation From the College of American Pathologists (CAP) for Its St. Louis Clinical Laboratory

Read more

The Future of Farming: Mechanization

Read more

Cofactor Genomics begins patient enrolment in NSCLC study of OncoPrism predictive diagnostic assay

Read more

Nutritional Outlook’s 2022 Best of the Industry Awards, Industry Leader: Brightseed

Read more

Special Series Part 3: AI Could Transform Medical Imaging — So Why Don’t We See It More?

Read more
« Older Entries
Next Entries »

Related Posts

  • Neuros Medical Nerve Block Technology
    iSelect Portfolio: Neuros Medical Closes $20 Million Funding Round
  • Market network
    What Is a Market Network?
  • Investing in Pharmaceuticals
    Expensive EpiPens Aren’t the Problem, Barriers to Innovation Are
  • iSelect
    Beyond Silicon Valley: Unlocking Hidden Opportunities in America's Untapped Industries
  • Jon Snyder
    Jon Snyder: An American Entrepreneur
AgTechFund BLOG SIDEBAR

(314) 219-8688

7750 Maryland Ave
Box 11826
St. Louis, MO 63105

Crunchbase   Twitter   LinkedIn   Facebook   YouTube

Securities offered through North Capital Private Securities ("NCPS"), Member FINRA/SIPC, located at 623 East Ft. Union Blvd, Suite 101, Salt Lake City, UT 84047. NCPS does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform.  Please review North Capital’s Form CRS and its background on FINRA’s BrokerCheck.  Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results.  All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.